PD-L1

Keytruda

Pharma

Merck's Keytruda eyes updated stomach cancer label

After scoring accelerated approval in stomach cancer, the drug has now shown it can stave off tumor progression in those with PD-L1 positive tumors.

Zoey Becker Jun 16, 2023 11:29am

Incyte

Incyte's PD-1 approved to treat rare cancer

Mar 22, 2023 6:20pm

Bladder anatomy

BMS' Opdivo-Yervoy combo flopped in first-line bladder cancer

May 16, 2022 9:00am